GlassScriptPhysician profile
Long Ht Le
NPI 1336451525
$267.25
in general payments reported to CMS, 2019-2025
11 companies · $36.49 in 2025
The $36.49 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.11 · 2021: $78.58 · 2022: $71.97 · 2023: $33.10 · 2025: $36.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $42.17 | 2021 | |
| Boston Scientific Corporation | $40.55 | 2022-2023 | |
| Sarepta Therapeutics, INC. | $34.10 | 2022 | |
| Glaxosmithkline, LLC. | $32.97 | 2019 | |
| Novo Nordisk INC | $22.41 | 2021 | |
| Abbvie INC. | $19.59 | 2025 | |
| Cranial Technologies, INC | $16.90 | 2025 | Doc Band |
| Lilly USA, LLC | $16.36 | 2022 | |
| Merck Sharp & Dohme LLC | $14.14 | 2019 | |
| Redhill Biopharma INC. | $14.06 | 2023 | Movantik, Aemcolo, Talicia |
| Pfizer INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Long Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.